Edge Therapeutics, Inc. Underwriting Agreements
4 Contracts & Agreements
- Underwriting Agreement, dated June 15, 2021, by and among PDS Biotechnology Corporation and Cantor Fitzgerald & Co (Filed With SEC on June 17, 2021)
- Underwriting Agreement dated August 11, 2020 (Filed With SEC on August 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 17, 2020)
- EDGE THERAPEUTICS, INC. Common Stock, par value $0.00033 pershare UNDERWRITING AGREEMENT (Filed With SEC on September 21, 2015)
